Fig. 4From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancerRisk of death according to CA-125 changes 3 (a) and 6 (b) months after the treatment. Both splins present increased risk of death along with increased change of CA-125. Linear effect was statistically significant 3 and 6 months after the treatmentBack to article page